Oric Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
ORIC Pharmaceuticals, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 18, 2026, to be held virtually, with key proposals including director elections, auditor ratification, and equity plan approval.
NASDAQ
ORIC Pharmaceuticals will hold its annual stockholders meeting on June 11, 2025, with proposals including the election of directors and ratification of KPMG LLP as the independent auditor.
NASDAQ
ORIC Pharmaceuticals will hold its 2025 Annual Meeting of Stockholders virtually on June 11, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
ORIC Pharmaceuticals will hold its annual meeting of stockholders on June 12, 2024, to elect directors and ratify the appointment of KPMG LLP as its independent accounting firm.
NASDAQ
ORIC Pharmaceuticals announces its 2024 Annual Meeting of Stockholders to be held virtually on June 12, 2024, to elect directors and ratify the appointment of its independent accounting firm.